| Product Code: ETC8546245 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Pneumococcal Vaccine Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Netherlands Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Netherlands Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Netherlands Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Netherlands Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Netherlands Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Netherlands Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in the Netherlands |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Rising prevalence of pneumococcal diseases in the region |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines |
4.3.2 Limited access to vaccination in certain regions of the Netherlands |
4.3.3 Concerns about vaccine safety and side effects |
5 Netherlands Pneumococcal Vaccine Market Trends |
6 Netherlands Pneumococcal Vaccine Market, By Types |
6.1 Netherlands Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Netherlands Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Netherlands Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Netherlands Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Netherlands Pneumococcal Vaccine Market Export to Major Countries |
7.2 Netherlands Pneumococcal Vaccine Market Imports from Major Countries |
8 Netherlands Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Number of individuals vaccinated against pneumococcal diseases |
8.2 Rate of vaccination coverage in different age groups |
8.3 Percentage of healthcare facilities offering pneumococcal vaccination |
8.4 Number of reported cases of pneumococcal diseases in the Netherlands |
8.5 Public perception and trust in pneumococcal vaccines |
9 Netherlands Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Netherlands Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Netherlands Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Netherlands Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Netherlands Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Netherlands Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Netherlands Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here